Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-κB Signaling

Demethyleneberberine (DMB) is an essential metabolite of Berberine (BBR) in vivo. Recent reports have revealed multiple novel therapeutic applications of BBR. However, the pharmacological activities of DMB remain to be elucidated. This study aimed to demonstrate the hepatoprotective and anti-fibroti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yongchen, Zhao, Zheng, Yan, Yan, Qiang, Xiaoyan, Zhou, Cuisong, Li, Ruiyan, Chen, Huan, Zhang, Yubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964412/
https://www.ncbi.nlm.nih.gov/pubmed/27376272
http://dx.doi.org/10.3390/ijms17071036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964412/
https://www.ncbi.nlm.nih.gov/pubmed/27376272
http://dx.doi.org/10.3390/ijms17071036

Ejemplares similares